Literature DB >> 1251926

Serum creatine phosphokinase in schizophrenia.

H Y Meltzer.   

Abstract

The author notes that increased serum creatine phosphokinase (CPK) activity is found in the majority of hospitalized acutely disturbed schizophrenics and patients with affective psychoses. It is probable that some of these increases do not result from nonspecific factors such as activity, trauma, or stress, which do cause increases in some cases. Those patients who show increased CPK activity have more florid psychopathology and tend to have higher CPK levels in nonacute periods than those without increases. First-degree relatives of psychotic patients with elevated serum CPK have high-normal or slightly increased serum CPK. There is also evidence of other neuromuscular dysfunction in psychotic patients. The author concludes that the investigation of CPK may have considerable heuristic value for the study of schizophrenia and other psychoses.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1251926     DOI: 10.1176/ajp.133.2.192

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  4 in total

Review 1.  Genetics and schizophrenic behavior.

Authors:  E Kahn
Journal:  Psychiatr Q       Date:  1980

Review 2.  Creatine metabolism and psychiatric disorders: Does creatine supplementation have therapeutic value?

Authors:  Patricia J Allen
Journal:  Neurosci Biobehav Rev       Date:  2012-03-24       Impact factor: 8.989

3.  Variational autoencoders learn transferrable representations of metabolomics data.

Authors:  Daniel P Gomari; Annalise Schweickart; Leandro Cerchietti; Elisabeth Paietta; Hugo Fernandez; Hassen Al-Amin; Karsten Suhre; Jan Krumsiek
Journal:  Commun Biol       Date:  2022-06-30

4.  Plasma creatine phosphokinase in schizophrenia.

Authors:  P Kondaiah; K K Murthy; O S Reddi
Journal:  Indian J Psychiatry       Date:  1981-10       Impact factor: 1.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.